Skip to content

Feasibility of a Wearable-enabled Intervention for Promoting Physical Activity in People Knee OA

Feasibility and Preliminary Efficacy of an Activity Tracker-driven Intervention for Promoting Physical Activity in People Living With Osteoarthritis of the Knee

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02313506
Acronym
TRACK-OA
Enrollment
34
Registered
2014-12-10
Start date
2015-01-31
Completion date
2015-06-30
Last updated
2019-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Joint Diseases, Knee Osteoarthritis

Keywords

Physical activity, Exercise, Osteoarthritis, Knee, Arthritis

Brief summary

Physical activity is an essential first-line treatment for patients with knee osteoarthritis (OA). However, a 2013 systematic review found only 13% met the activity recommendation of 150 minutes or more per week. The primary goal of this pilot randomized controlled trail is to assess the feasibility and preliminary efficacy of a multi-component intervention/model of care involving a group education session, use of the Fitbit Flex (a wireless physical activity tracking device), and weekly telephone counselling by a physiotherapist (PT) to improve physical activity and reduce sedentary time in patients with knee OA.

Detailed description

Knee osteoarthritis (OA) is common (affecting 1 in 10), painful, and debilitating. Being physically active improves pain, mobility and quality of life for people living with knee OA; however, less than half of patients are active. Combining the best evidence in OA care and digital technology, the investigators propose a new model of care for improving physical activity in patients with OA. The investigators primary objective is to determine the feasibility and preliminary efficacy of a multi-component model of care involving 1) a group education and structured goal-setting session, 2) the use of Fitbit Flex (a commercially available physical activity tracker) and 3) weekly telephone activity counselling by a physiotherapist for improving physical activity and reducing sedentary time in patients with knee OA. In this pilot randomized controlled trial the investigators hypothesize that compared to a control group (i.e. the Delayed Intervention group), participants in the Immediate Intervention Group will 1) increase moderate/vigorous physical activity (MVPA), 2) reduce sedentary time, 3) improve OA disease status, and 4) improve abilities to self-manage their condition.

Interventions

Participants will receive a brief education session, use of a commercially available physical activity tracker (Fitbit Flex), and remote counselling by a PT. Intervention will be received immediately.

BEHAVIORALSame intervention with a 1 month delay

The Delayed Intervention Group will receive the same intervention as the Immediate Intervention Group, but with a 1 Month delay.

Sponsors

Arthritis Research Centre of Canada
CollaboratorOTHER
Vancouver General Hospital
CollaboratorOTHER
University of British Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

This study used a delayed control design.

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Have a physician confirmed diagnosis of knee osteoarthritis OR are both 1) over 50, and 2) have experienced 4 weeks of pain, aching, or discomfort in or around the knee during the last year (equal to or more than 28 separate or consecutive days). * Have no previous diagnosis of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, polymyalgia rheumatica, connective tissue diseases, fibromyalgia or gout. * Have no history of using disease-modifying anti-rheumatic drugs or gout medications. * Have no prior knee replacement surgery, and not on a waiting list for total knee replacement surgery. * Have no history of acute injury to the knee in the past 6 months. * Have not had surgery in the back, hip, knee, foot or ankle joints in the past 12 months. * Have an email address and daily access to a computer with internet connection. * Be able to attend a 2-hour education session at the Mary Pack Arthritis Centre.

Exclusion criteria

* Have a body mass index of equal to or greater than 40 * Have received a steroid injection in a knee in the last 6 months * Have received a hyaluronate injection in a knee in the last 6 months * Use medication that may impair activity tolerance (e.g. beta blockers) * Are at risk when exercising, as identified by the Physical Activity Readiness Questionnaire (PAR-Q)

Design outcomes

Primary

MeasureTime frameDescription
Time Spent in Moderate-to-Vigorous Physical Activity (MVPA)Baseline; 1 month and 2 months from baselineParticipants wore a SenseWear Mini device for 7 days at baseline, and Months 1 and 2. We calculated the average time spent in MVPA accumulated in bouts per day. A bout is defined as 10 consecutive minutes or more at the level of 3 or higher METs, with allowance for interruption of up to 1 minute below the threshold.

Secondary

MeasureTime frameDescription
KOOS - SymptomsBaseline; 1 month and 2 months from baselineSymptoms were measured by Knee Injury and OA Outcome Score (KOOS). The KOOS measures knee osteoarthritis disease status and consists of five sub-scales: knee pain, stiffness, daily activity, sports/recreation, and quality of life. Scores range from 0 to 100, with higher being better.
KOOS - PainBaseline; 1 month and 2 months from baselinePain was measured by a Knee Injury and Osteoarthritis Outcome Score subscale. Scores range from 0 to 100, with higher being better.
KOOS - Activities of Daily LivingBaseline; 1 month and 2 months from baselineActivities of Daily Living was measured by Knee Injury and OA Outcome Score (KOOS). The KOOS measures knee osteoarthritis disease status and consists of five sub-scales: knee pain, stiffness, daily activity, sports/recreation, and quality of life. Scores range from 0 to 100, with higher being better.
Time Spent in Sedentary BehaviorBaseline; 1 month and 2 months from baselineWe calculated the average daily time spent with an energy expenditure of 1.5 METs or lower, occurring in bouts of \> 20 minutes during waking hours.
KOOS - Knee-related Quality of LifeBaseline; 1 month and 2 months from baselineQuality of life was measured by Knee Injury and OA Outcome Score (KOOS). The KOOS measures knee osteoarthritis disease status and consists of five sub-scales: knee pain, stiffness, daily activity, sports/recreation, and quality of life. Scores range from 0 to 100, with higher being better.
Partners in Health ScaleBaseline; 1 month and 2 months from baselineThe Partners in Health Scale is a 12-item measure designed to assess disease self-management abilities including knowledge of health conditions, ability to participate in decision-making with health care professionals, and ability to pursue a healthy lifestyle. Scores range from 0 to 96, with lower being better.
KOOS - Sport and Recreation FunctionBaseline; 1 month and 2 months from baselineSport and Recreation Function was measured by Knee Injury and OA Outcome Score (KOOS). The KOOS measures knee osteoarthritis disease status and consists of five sub-scales: knee pain, stiffness, daily activity, sports/recreation, and quality of life. Scores range from 0 to 100, with higher being better.

Countries

Canada

Participant flow

Recruitment details

Our recruitment strategy identified 46 eligible individuals. Recruitment was from January 2015 to March 2015. Participants were recruited from 1) postings on Facebook, Twitter, Kajiji, Craigslist, and the Arthritis Research Canada website, 2) emails sent by the Arthritis Consumer Experts the Vancouver Coastal Health Research Institute to its staff.

Participants by arm

ArmCount
Immediate Intervention Group
Education session, Fitbit Flex, and remote coaching by a PT. These three components of the intervention will be delivered to the participants in Month 1. At the end of the education session, the PT will help participants set personal activity goals. In Month 1, participants will use the Fitbit Flex. The PT will review the progress with participants via 20-minute weekly phone calls and progressively modify their activities. In Month 2, they will continue using the Fitbit and have access to a PT via email as needed, but no weekly phone calls. Education session, Fitbit Flex, and remote coaching by a PT: Participants will receive a brief education session, use of a commercially available physical activity tracker (Fitbit Flex), and remote counselling by a PT. Intervention will be received immediately.
17
Delayed Intervention Group
Same intervention with a 1 month delay: The full intervention will be initiated in Month 2 with a brief education session, use of Fitbit Flex, and counselling by a physiotherapist. The trial will conclude at the end of Month 2. Same intervention with a 1 month delay: The Delayed Intervention Group will receive the same intervention as the Immediate Intervention Group, but with a 1 Month delay.
17
Total34

Baseline characteristics

CharacteristicTotalDelayed Intervention GroupImmediate Intervention Group
Age, Continuous55.5 years
STANDARD_DEVIATION 8.6
58.7 years
STANDARD_DEVIATION 6
52.3 years
STANDARD_DEVIATION 9.7
Body Mass Index27.2 kg/m^2
STANDARD_DEVIATION 4.7
25.4 kg/m^2
STANDARD_DEVIATION 4.2
29.1 kg/m^2
STANDARD_DEVIATION 4.5
Comorbid conditions2.5 comorbid conditions2 comorbid conditions3 comorbid conditions
Compared to one year ago, how would you rate your health in general?
About the same
27 Participants12 Participants15 Participants
Compared to one year ago, how would you rate your health in general?
Much better
1 Participants0 Participants1 Participants
Compared to one year ago, how would you rate your health in general?
Much worse
0 Participants0 Participants0 Participants
Compared to one year ago, how would you rate your health in general?
Somewhat better
1 Participants1 Participants0 Participants
Compared to one year ago, how would you rate your health in general?
Somewhat worse
5 Participants4 Participants1 Participants
Diagnosed with OA
No, but met the 'likely OA' criteria
14 Participants8 Participants6 Participants
Diagnosed with OA
Yes
20 Participants9 Participants11 Participants
Gross annual household income
$12,001 - $24,000
1 Participants1 Participants0 Participants
Gross annual household income
$24,001 - $40,000
2 Participants2 Participants0 Participants
Gross annual household income
$40,001 - $60,000
5 Participants1 Participants4 Participants
Gross annual household income
$60,001 - $80,000
0 Participants0 Participants0 Participants
Gross annual household income
$80,001 - $100,000
3 Participants1 Participants2 Participants
Gross annual household income
No answer
7 Participants4 Participants3 Participants
Gross annual household income
Over $100,000
14 Participants7 Participants7 Participants
Gross annual household income
Under $12,000
2 Participants1 Participants1 Participants
In general, would you say your health is ...
Excellent
6 Participants1 Participants5 Participants
In general, would you say your health is ...
Fair
4 Participants1 Participants3 Participants
In general, would you say your health is ...
Good
13 Participants9 Participants4 Participants
In general, would you say your health is ...
Poor
0 Participants0 Participants0 Participants
In general, would you say your health is ...
Very good
11 Participants6 Participants5 Participants
Marital Status
Married/Common Law
25 Participants14 Participants11 Participants
Marital Status
Separated/ Divorced
5 Participants1 Participants4 Participants
Marital Status
Widowed/ Never Married/ Other
4 Participants2 Participants2 Participants
Region of Enrollment
Canada
34 participants17 participants17 participants
Sex: Female, Male
Female
28 Participants14 Participants14 Participants
Sex: Female, Male
Male
6 Participants3 Participants3 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 170 / 17
other
Total, other adverse events
0 / 170 / 17
serious
Total, serious adverse events
0 / 170 / 17

Outcome results

Primary

Time Spent in Moderate-to-Vigorous Physical Activity (MVPA)

Participants wore a SenseWear Mini device for 7 days at baseline, and Months 1 and 2. We calculated the average time spent in MVPA accumulated in bouts per day. A bout is defined as 10 consecutive minutes or more at the level of 3 or higher METs, with allowance for interruption of up to 1 minute below the threshold.

Time frame: Baseline; 1 month and 2 months from baseline

Population: The number of participants analyzed is the same as the number of participants assigned to each group.

ArmMeasureGroupValue (MEAN)Dispersion
Immediate Intervention GroupTime Spent in Moderate-to-Vigorous Physical Activity (MVPA)Baseline41.3 Minutes per dayStandard Deviation 51.6
Immediate Intervention GroupTime Spent in Moderate-to-Vigorous Physical Activity (MVPA)1 Month64.2 Minutes per dayStandard Deviation 70.5
Immediate Intervention GroupTime Spent in Moderate-to-Vigorous Physical Activity (MVPA)2 Months67.7 Minutes per dayStandard Deviation 85.8
Delayed Intervention GroupTime Spent in Moderate-to-Vigorous Physical Activity (MVPA)Baseline66.5 Minutes per dayStandard Deviation 71
Delayed Intervention GroupTime Spent in Moderate-to-Vigorous Physical Activity (MVPA)1 Month56.0 Minutes per dayStandard Deviation 60.1
Delayed Intervention GroupTime Spent in Moderate-to-Vigorous Physical Activity (MVPA)2 Months81.9 Minutes per dayStandard Deviation 64.4
Comparison: ANCOVA was performed to evaluate the effect of the group type on the outcome measures after adjusting for blocking and baseline (T0). We assessed 3 planned contrasts of changes in outcome measures over time. Contrast 1 compared T0-T1 between the 2 groups to determine if the intervention was superior to the control.p-value: 0.0295% CI: [-56.6, -5.7]ANCOVA
Comparison: ANCOVA was performed to evaluate the effect of the group type on the outcome measures after adjusting for blocking and baseline (T0). We assessed 3 planned contrasts of changes in outcome measures over time. Contrast 2 compared T0-T1 in the immediate group against T1-T2 in the delayed group.p-value: 0.7195% CI: [-19.6, 28.9]ANCOVA
Comparison: ANCOVA was performed to evaluate the effect of the group type on the outcome measures after adjusting for blocking and baseline (T0). We assessed 3 planned contrasts of changes in outcome measures over time. Contrast 3 compared T0-T1 in the immediate group against T0-T2 in the delayed group.p-value: 0.2995% CI: [-31.1, 9.1]ANCOVA
Secondary

KOOS - Activities of Daily Living

Activities of Daily Living was measured by Knee Injury and OA Outcome Score (KOOS). The KOOS measures knee osteoarthritis disease status and consists of five sub-scales: knee pain, stiffness, daily activity, sports/recreation, and quality of life. Scores range from 0 to 100, with higher being better.

Time frame: Baseline; 1 month and 2 months from baseline

Population: The number of participants analyzed is the same as the number of participants assigned to each group.

ArmMeasureGroupValue (MEAN)Dispersion
Immediate Intervention GroupKOOS - Activities of Daily LivingBaseline81.8 score on a scaleStandard Deviation 17.1
Immediate Intervention GroupKOOS - Activities of Daily Living1 Month75.1 score on a scaleStandard Deviation 19.7
Immediate Intervention GroupKOOS - Activities of Daily Living2 Months83 score on a scaleStandard Deviation 14.9
Delayed Intervention GroupKOOS - Activities of Daily LivingBaseline78.3 score on a scaleStandard Deviation 15.9
Delayed Intervention GroupKOOS - Activities of Daily Living1 Month79.1 score on a scaleStandard Deviation 18.9
Delayed Intervention GroupKOOS - Activities of Daily Living2 Months82.2 score on a scaleStandard Deviation 17.1
Secondary

KOOS - Knee-related Quality of Life

Quality of life was measured by Knee Injury and OA Outcome Score (KOOS). The KOOS measures knee osteoarthritis disease status and consists of five sub-scales: knee pain, stiffness, daily activity, sports/recreation, and quality of life. Scores range from 0 to 100, with higher being better.

Time frame: Baseline; 1 month and 2 months from baseline

Population: The number of participants analyzed is the same as the number of participants assigned to each group.

ArmMeasureGroupValue (MEAN)Dispersion
Immediate Intervention GroupKOOS - Knee-related Quality of LifeBaseline53.3 score on a scaleStandard Deviation 18.4
Immediate Intervention GroupKOOS - Knee-related Quality of Life1 Month51.8 score on a scaleStandard Deviation 19.5
Immediate Intervention GroupKOOS - Knee-related Quality of Life2 Months56.6 score on a scaleStandard Deviation 20.2
Delayed Intervention GroupKOOS - Knee-related Quality of LifeBaseline47.4 score on a scaleStandard Deviation 16.1
Delayed Intervention GroupKOOS - Knee-related Quality of Life1 Month48.9 score on a scaleStandard Deviation 19.3
Delayed Intervention GroupKOOS - Knee-related Quality of Life2 Months52.3 score on a scaleStandard Deviation 18
Secondary

KOOS - Pain

Pain was measured by a Knee Injury and Osteoarthritis Outcome Score subscale. Scores range from 0 to 100, with higher being better.

Time frame: Baseline; 1 month and 2 months from baseline

Population: The number of participants analyzed is the same as the number of participants assigned to each group.

ArmMeasureGroupValue (MEAN)Dispersion
Immediate Intervention GroupKOOS - Pain1 Month71.4 score on a scaleStandard Deviation 17.5
Immediate Intervention GroupKOOS - Pain2 Months79.1 score on a scaleStandard Deviation 13
Immediate Intervention GroupKOOS - PainBaseline74.5 score on a scaleStandard Deviation 16.2
Delayed Intervention GroupKOOS - PainBaseline68.6 score on a scaleStandard Deviation 16.1
Delayed Intervention GroupKOOS - Pain1 Month71.6 score on a scaleStandard Deviation 15.2
Delayed Intervention GroupKOOS - Pain2 Months74 score on a scaleStandard Deviation 15.4
Secondary

KOOS - Sport and Recreation Function

Sport and Recreation Function was measured by Knee Injury and OA Outcome Score (KOOS). The KOOS measures knee osteoarthritis disease status and consists of five sub-scales: knee pain, stiffness, daily activity, sports/recreation, and quality of life. Scores range from 0 to 100, with higher being better.

Time frame: Baseline; 1 month and 2 months from baseline

Population: The number of participants analyzed is the same as the number of participants assigned to each group.

ArmMeasureGroupValue (MEAN)Dispersion
Immediate Intervention GroupKOOS - Sport and Recreation FunctionBaseline55.6 score on a scaleStandard Deviation 29.5
Immediate Intervention GroupKOOS - Sport and Recreation Function1 Month54.7 score on a scaleStandard Deviation 28.3
Immediate Intervention GroupKOOS - Sport and Recreation Function2 Months64.4 score on a scaleStandard Deviation 28.4
Delayed Intervention GroupKOOS - Sport and Recreation FunctionBaseline51.2 score on a scaleStandard Deviation 26
Delayed Intervention GroupKOOS - Sport and Recreation Function1 Month54.4 score on a scaleStandard Deviation 31.4
Delayed Intervention GroupKOOS - Sport and Recreation Function2 Months55.6 score on a scaleStandard Deviation 22.6
Secondary

KOOS - Symptoms

Symptoms were measured by Knee Injury and OA Outcome Score (KOOS). The KOOS measures knee osteoarthritis disease status and consists of five sub-scales: knee pain, stiffness, daily activity, sports/recreation, and quality of life. Scores range from 0 to 100, with higher being better.

Time frame: Baseline; 1 month and 2 months from baseline

Population: The number of participants analyzed is the same as the number of participants assigned to each group.

ArmMeasureGroupValue (MEAN)Dispersion
Immediate Intervention GroupKOOS - SymptomsBaseline70.6 score on a scaleStandard Deviation 15.8
Immediate Intervention GroupKOOS - Symptoms1 Month68.3 score on a scaleStandard Deviation 18.4
Immediate Intervention GroupKOOS - Symptoms2 Months72.5 score on a scaleStandard Deviation 20.2
Delayed Intervention GroupKOOS - SymptomsBaseline70.4 score on a scaleStandard Deviation 14.9
Delayed Intervention GroupKOOS - Symptoms1 Month66.8 score on a scaleStandard Deviation 18.2
Delayed Intervention GroupKOOS - Symptoms2 Months73.2 score on a scaleStandard Deviation 15.4
Secondary

Partners in Health Scale

The Partners in Health Scale is a 12-item measure designed to assess disease self-management abilities including knowledge of health conditions, ability to participate in decision-making with health care professionals, and ability to pursue a healthy lifestyle. Scores range from 0 to 96, with lower being better.

Time frame: Baseline; 1 month and 2 months from baseline

Population: The number of participants analyzed is the same as the number of participants assigned to each group.

ArmMeasureGroupValue (MEAN)Dispersion
Immediate Intervention GroupPartners in Health ScaleBaseline21.9 score on a scaleStandard Deviation 17.6
Immediate Intervention GroupPartners in Health Scale1 Month17.2 score on a scaleStandard Deviation 17
Immediate Intervention GroupPartners in Health Scale2 Months21.6 score on a scaleStandard Deviation 21.9
Delayed Intervention GroupPartners in Health ScaleBaseline26.8 score on a scaleStandard Deviation 15.3
Delayed Intervention GroupPartners in Health Scale1 Month31.9 score on a scaleStandard Deviation 17.9
Delayed Intervention GroupPartners in Health Scale2 Months22.9 score on a scaleStandard Deviation 15.2
Secondary

Time Spent in Sedentary Behavior

We calculated the average daily time spent with an energy expenditure of 1.5 METs or lower, occurring in bouts of \> 20 minutes during waking hours.

Time frame: Baseline; 1 month and 2 months from baseline

Population: The number of participants analyzed is the same as the number of participants assigned to each group.

ArmMeasureGroupValue (MEAN)Dispersion
Immediate Intervention GroupTime Spent in Sedentary BehaviorBaseline548.4 Minutes per dayStandard Deviation 169.1
Immediate Intervention GroupTime Spent in Sedentary Behavior1 Month524.9 Minutes per dayStandard Deviation 192.1
Immediate Intervention GroupTime Spent in Sedentary Behavior2 Months523.9 Minutes per dayStandard Deviation 200.2
Delayed Intervention GroupTime Spent in Sedentary BehaviorBaseline453.3 Minutes per dayStandard Deviation 180.5
Delayed Intervention GroupTime Spent in Sedentary Behavior1 Month492.8 Minutes per dayStandard Deviation 164.8
Delayed Intervention GroupTime Spent in Sedentary Behavior2 Months393.1 Minutes per dayStandard Deviation 144.2

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026